Ada Patient Finder -- Daily Briefing

Wednesday, February 11, 2026 -- 7:00 AM ET
Snapshot: 2026-02-11
Pipeline Snapshot
€96,748,612
Total Pipeline (Unweighted)
€7,892,184
Weighted Pipeline
134
Open Opps
€0
Closing This Quarter
0
Calls Yesterday
1.0
7-Day Avg Calls
69
Stale Deals
Stage Moves (Last 24h)
No stage changes in the last 24 hours
Pipeline Changes
No pipeline changes
Stale Deals (14+ Days Since Last Contact)
Crohns Colitis Foundation 377d No Contact
Jacob Plummer | Qualification | 5% | €420,574
Ontario Enhancements - Suicide Pop Up - Delivery 266d No Contact
Simon Wolpert | Qualification | 5% | €248,243
Ontario SOW9 - Health Care Connect (Primary Care Attachment) - Planning Only 207d No Contact
Simon Wolpert | Proposal | 30% | €31,030
Astrazeneca - Wainua 160d No Contact
Usaid Cheema | Qualification | 5% | €500,000
Walgreens/Boots 156d No Contact
Randal Whitmore | Qualification | 5% | €420,574
Patient Finder for Temple Health 155d No Contact
Randal Whitmore | Qualification | 5% | €420,574
Health 811 SOW9 - HCC + Survey Planning + Delivery 148d No Contact
Simon Wolpert | Proposal | 30% | €93,091
DKV Seguros 142d No Contact
Johannes Vonhuelsen | Discovery | 10% | €486,000
GSK - Shingrix 126d No Contact
Usaid Cheema | Qualification | 5% | €420,574
Alberta Health Services - Patient Portal (via Orion & Telus/IBM) 95d No Contact
Simon Wolpert | Qualification | 5% | €4,809,721
+59 more stale deals
No Decision Maker Engaged
AbbVie - Botox No DM
Usaid Cheema | Qualification | 5% | €420,574
AbbVie - Rinvoq No DM
Usaid Cheema | Qualification | 5% | €420,574
AbbVie - Vraylar No DM
Usaid Cheema | Qualification | 5% | €500,000
ACADIA Pharmaceuticals | Daybue | Rett syndrome No DM
Usaid Cheema | Qualification | 5% | €420,574
Acorda Therapeutics | Ampyra | Multiple sclerosis (improve walking) No DM
Usaid Cheema | Qualification | 5% | €420,574
Aetna a CVS Health Company No DM
Simon Wolpert | Qualification | 5% | €252,344
Alberta Health Services - Patient Portal (via Orion & Telus/IBM) No DM
Simon Wolpert | Qualification | 5% | €4,809,721
Alkermes - Libalvi No DM
Usaid Cheema | Qualification | 5% | €500,000
+20 more
Flagged Calls (< 3.0)
No flagged calls
Calls Yesterday (0)
No calls recorded yesterday
Top Deals by Value
GNAL
Qualification | 5%
€20,500,000
Biogen | Friedreichs Ataxia | Global - Phase 2
Qualification | 5%
€6,000,000
Blue Shield of California
Proposal | 30%
€5,467,468
Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
Qualification | 5%
€4,809,721
Resmed Phase 2
Qualification | 5%
€2,523,447
SANOFI | Diabetes | TZIELD | US - Phase 2
Discovery | 10%
€2,523,447
Biogen Germany FA extension
Discovery | 10%
€2,100,000
Blue Cross Blue Shield Arizona
Qualification | 5%
€1,429,953
Pharma Intel -- Urgent
**1. Sanofi completes Dynavax acquisition (Feb 10) -- Paul Hudson making AI-forward moves**
Sanofi closed the Dynavax deal, adding HEPLISAV-B (hep B vaccine) and a shingles candidate. Hudson published a Fortune piece on Feb 10 positioning Sanofi as the AI-first pharma company: 10 new drug targets discovered in one year via ML, 65% improveme
- [Sanofi completes Dynavax acquisition](https://www.globenewswire.com/news-release/2026/02/10/3235419/0/en/Press-Release-Sanofi-completes-the-acquisition-of-Dynavax.html)
- [Hudson on AI reshaping pharma](https://fortune.com/2026/02/10/sanofi-ceo-paul-hudson-predictions-2026-ai-transformation/)
- [Venglustat Phase 3 success in Type 3 Gaucher](https://www.statnews.com/2026/02/02/sanofi-venglustat-gaucher-rare-disease-neurological-symptoms/)
- [Rilzabrutinib FDA Breakthrough in warm AIHA](https://www.pharmabiz.com/NewsDetails.aspx?aid=184157&sid=2)
**2. Victor Bulto (Novartis US) quoted on radiopharmaceuticals, now on Labcorp board**
Bulto was quoted Feb 9 on Novartis's radiopharmaceutical strategy ("What we are doing has activated the whole space"). He also joined Labcorp's board in Dec 2025. Both signal he remains highly active and visible -- good timing for Andrea Marazzi foll
Meetings Today
11:00 AM -- yury@glenviewrecords.com
Yury/Daniel
2:00 PM
Strategy Block
System Health
Cron Jobs0 active
Stale Tasks4